Abstract 96: Elucidating the role of CXCL17/GPR35 axis in breast cancer bone metastasis

Abstract Breast cancer (BC) has a high propensity to metastasize to the bone, but the molecular mechanisms driving bone metastasis (BoM) are not yet fully understood. BC cells establish bidirectional interactions with the bone microenvironment through altered expression of several chemokines and their receptors to facilitate metastasis and niche formation. Various G protein-coupled receptors are involved in oncogenic processes. Recently, it has been reported that G protein-coupled receptor 35 (GPR35), a cognate receptor for CXCL17, plays a significant role in tumor progression, metastasis, and drug resistance; however, its role in the modulation of bone microenvironment has not been elucidated. Here, we analyzed the expression of GPR35 in BC patients using the TCGA database. Furthermore, we also employed immunohistochemistry to examine the expression profile of GPR35 in BC tissue microarray. Our findings revealed high GPR35 expression in BC relative to the normal breast tissue. High GPR35 expression in BC also correlated positively with poor patient outcomes. Moreover, GPR35 expression was elevated in human as well as syngeneic BC bone metastatic cell lines (SCP2, SCP28, and E0771/Bone) compared to their relative parental cell lines (MDA-MB-231 and E0771P), advocating its significant potential in bone metastasis. Since most of the BC bone metastasis is osteolytic (bone destructive) in nature, and osteoblasts (OBs) regulate the osteoclasts (OCs) functions, therefore we examined the effect of conditioned media (CM) from the BC cells treated with either vehicle or rhCXCL17 on OBs and OCs. BC-CM induced bone cell differentiation, which was remarkably significant in OBs and OCs treated with BC-CM of rhCXCL17-treated cells. Together, these findings highlight the critical role of the CXCL17/GPR35 signaling axis in bone microenvironment remodeling supporting BC cell colonization. Citation Format: Gunjan Sharma, K. M. Abdullah, Seema Singh, Ajay P. Singh, Jawed A. Siddiqui. Elucidating the role of CXCL17/GPR35 axis in breast cancer bone metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 96.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-96
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 96: Elucidating the role of CXCL17/GPR35 axis in breast cancer bone metastasis

Ajay P. Singh, Gunjan Sharma, Jawed A. Siddiqui, K.M. Abdullah et al.
Cancer Research
Inflammatory mediators and NSAID effects
article

Abstract 96: Elucidating the role of CXCL17/GPR35 axis in breast cancer bone metastasis

Ajay P. Singh, Gunjan Sharma, Jawed A. Siddiqui, K.M. Abdullah, Seema Singh
article en

Abstract

Abstract Breast cancer (BC) has a high propensity to metastasize to the bone, but the molecular mechanisms driving bone metastasis (BoM) are not yet fully understood. BC cells establish bidirectional interactions with the bone microenvironment through altered expression of several chemokines and their receptors to facilitate metastasis and niche formation. Various G protein-coupled receptors are involved in oncogenic processes. Recently, it has been reported that G protein-coupled receptor 35 (GPR35), a cognate receptor for CXCL17, plays a significant role in tumor progression, metastasis, and drug resistance; however, its role in the modulation of bone microenvironment has not been elucidated. Here, we analyzed the expression of GPR35 in BC patients using the TCGA database. Furthermore, we also employed immunohistochemistry to examine the expression profile of GPR35 in BC tissue microarray. Our findings revealed high GPR35 expression in BC relative to the normal breast tissue. High GPR35 expression in BC also correlated positively with poor patient outcomes. Moreover, GPR35 expression was elevated in human as well as syngeneic BC bone metastatic cell lines (SCP2, SCP28, and E0771/Bone) compared to their relative parental cell lines (MDA-MB-231 and E0771P), advocating its significant potential in bone metastasis. Since most of the BC bone metastasis is osteolytic (bone destructive) in nature, and osteoblasts (OBs) regulate the osteoclasts (OCs) functions, therefore we examined the effect of conditioned media (CM) from the BC cells treated with either vehicle or rhCXCL17 on OBs and OCs. BC-CM induced bone cell differentiation, which was remarkably significant in OBs and OCs treated with BC-CM of rhCXCL17-treated cells. Together, these findings highlight the critical role of the CXCL17/GPR35 signaling axis in bone microenvironment remodeling supporting BC cell colonization. Citation Format: Gunjan Sharma, K. M. Abdullah, Seema Singh, Ajay P. Singh, Jawed A. Siddiqui. Elucidating the role of CXCL17/GPR35 axis in breast cancer bone metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 96.

Cancer ResearchVol. 85(8_Supplement_1)
Jackson Memorial Hospital (US), University of Mississippi Medical Center (US)
Openalex Percentile: Top 90%
Inflammatory mediators and NSAID effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.